Question explored with the scientific record
Cough
The short version: most acute cough is viral, self-limited, and does not need a drug. The evidence for cough medicines is thin, old, and often industry-funded.
A 2020 German guideline [1] and a 2006 pediatric position statement [17] agree: acute cough from a viral upper respiratory infection usually resolves on its own. The pediatric statement is blunt: over-the-counter and prescription cough medications are generally ineffective for symptomatic relief of acute cough in children [17]. The German guideline covers adults and recommends treating the underlying cause, not the cough itself [1].
The drug studies here are old and small. A 1983 crossover trial of 16 adults with chronic cough found dextromethorphan and codeine both reduced cough frequency and intensity versus placebo, but the study was tiny and the patients had serious lung disease (tuberculosis, cancer) [13]. A 1984 study of glaucine, a non-narcotic, compared it to codeine in 90 patients with acute and chronic cough and reported better cough scores and zero side effects for glaucine versus nine for codeine [12]. Both studies are decades old, funded by manufacturers (the glaucine paper does not name the funder but the authors were from a pharmaceutical company), and use subjective scoring, not hard outcomes.
A 2024 Ukrainian study of a codeine combination product for dry post-viral cough reported faster cough reduction on a visual scale and better quality-of-life scores compared to an alternative [14]. The study was not blinded against placebo, and the comparator was another active drug, not no treatment. The evidence does not show that suppressing a cough changes the course of the illness.
| Intervention | Population | Outcome | Evidence quality |
|---|---|---|---|
| Dextromethorphan 20 mg | 16 adults, chronic cough | Reduced frequency and intensity vs placebo | Low (tiny, old, industry) |
| Codeine 20 mg | Same 16 adults | Similar to dextromethorphan | Low (same study) |
| Glaucine 30 mg | 90 adults, acute/chronic cough | Better cough scores than codeine, no side effects | Low (old, manufacturer-funded) |
| Codeine combination (Kodesan IS) | Adults, dry post-viral cough | Faster VAS reduction vs alternative active drug | Low (no placebo, unblinded) |
| QingfengGanke granule | 173 adults, postinfectious cough | Reduced cough duration vs placebo (8 vs >10 days) | Moderate (RCT, Chinese herbal, single formulation) |
The 2015 Chinese trial of QingfengGanke granule is the strongest study here: a multicenter, randomized, double-blind, placebo-controlled trial in 173 adults with postinfectious cough [11]. High-dose (12 g twice daily) reduced median cough resolution time to 8 days versus more than 10 days for placebo. The study was funded by a Chinese pharmaceutical company, and the herbal formulation is not available in most countries.
For children, the evidence is even thinner. A 2015 Vietnamese study of 1,082 hospitalized children found rhinovirus and RSV as the top causes of acute respiratory infection [4]. A 2024 Romanian study of 496 hospitalized children found rhinovirus in 28% of cases, with cough present in 64% [5]. Neither study tested any cough treatment. The pediatric guideline says most acute cough is viral and does not require medication [17].
My call: for a healthy adult or child with an acute cough from a viral infection, the evidence does not support using any cough medicine. The drugs have small, inconsistent effects in old, low-quality studies. The body clears the virus on its own. Confidence: moderate.
Sources used 8
-
German Respiratory Society guidelines for diagnosis and treatment of adults suffering from acute, subacute and chronic cough
A comprehensive S2k consensus guideline from the German Respiratory Society for diagnosis and treatment of adults with acute, subacute, and chronic cough, detailing etiologies, diagnostic algorithms, and evidence- and consensus-based treatment recommendations.
DOI: 10.1016/j.rmed.2020.105939 -
Clinical and epidemiological characteristics of acute respiratory virus infections in Vietnamese children
A prospective study of 1082 hospitalized Vietnamese children with acute respiratory infections identifying the viral etiologies (notably HRV, RSV and HBoV), their seasonal patterns, age distributions, and associations with clinical severity to inform diagnosis and treatment in r…
DOI: 10.1017/S095026881500134X -
Exploring the Clinical Characteristics and Outcomes of Rhinovirus Infection in Hospitalized Children Compared with Other Respiratory Viruses
A retrospective study of 496 children hospitalized with influenza-like illness in Romania found rhinovirus to be the most prevalent respiratory virus, with rhinovirus infection not having distinctive clinical signs but associated with lower antibiotic use and higher risk of cert…
DOI: 10.3390/children11111303 -
The efficacy of QingfengGanke granule in treating postinfectious cough in pathogenic wind invading lungs syndrome: a multicenter, randomized, double-blind, placebo-controlled trial
QingfengGanke granule is efficacious in treating postinfectious cough with pathogenic wind invading lungs syndrome, reducing cough duration and severity compared to placebo.
DOI: 10.1186/s13020-015-0049-6 -
Efficacy and tolerability of glaucine as an antitussive agent
This study evaluates the efficacy and tolerability of glaucine, a non-narcotic antitussive agent, in comparison to codeine through two clinical trials involving patients with acute and chronic cough.
DOI: 10.1185/03007998409109554 -
Dextromethorphan and Codeine: Objective Assessment of Antitussive Activity in Patients with Chronic Cough
In a double-blind, crossover trial of sixteen adults with chronic cough, dextromethorphan and codeine both reduced cough frequency and intensity versus placebo, with dextromethorphan producing greater attenuation of cough intensity and a strong patient preference, suggesting it …
DOI: 10.1177/030006058301100206 -
Modern Treatment of Dry Post-viral Cough. Focus on Efficiency and Safety
In adults with a dry post-viral cough after ARVI, a 5‑day course of Kodesan IS (codeine, thermopsis extract, licorice root, sodium bicarbonate) produced faster and greater reductions in cough intensity and improved physical, psychological, and social quality of life compared wit…
DOI: 10.30841/2786-720x.1.2024.300462 -
Cough in children: definitions and clinical evaluation
This Australasian Thoracic Society and New Zealand Thoracic Society position statement defines pediatric cough by duration and quality, delineates categories of cough (expected, specific, nonspecific), and provides evidence‑based recommendations for clinical evaluation and manag…
DOI: 10.5694/j.1326-5377.2006.tb00290.x